Literature DB >> 19401541

Proteases display biased agonism at protease-activated receptors: location matters!

Angela Russo1, Unice J K Soh, JoAnn Trejo.   

Abstract

Protease-activated receptors (PARs) are G protein-coupled receptors (GPCRs) that transmit cellular responses begun by the actions of extracellular proteases. The activation of a PAR occurs by a unique mechanism whereby the extracellular N-terminal segment of the inactive receptor undergoes proteolytic cleavage, resulting in irreversible activation--unlike most GPCRs that are reversibly activated. PARs mediate cellular responses to coagulant proteases in various cell types localized within the vasculature. Additionally, PARs are expressed in other cell types and respond to a plethora of proteases. Recent studies have revealed that different proteases elicit distinct responses through the activation of the same PAR. This phenomenon appears to involve stabilization of distinct active PAR conformations that facilitates selectively coupling to different effectors and is localized to caveolae, a subtype of lipid rafts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19401541      PMCID: PMC3139377          DOI: 10.1124/mi.9.2.8

Source DB:  PubMed          Journal:  Mol Interv        ISSN: 1534-0384


  73 in total

1.  Swf1-dependent palmitoylation of the SNARE Tlg1 prevents its ubiquitination and degradation.

Authors:  Javier Valdez-Taubas; Hugh Pelham
Journal:  EMBO J       Date:  2005-06-23       Impact factor: 11.598

Review 2.  Protease-activated receptors in hemostasis, thrombosis and vascular biology.

Authors:  S R Coughlin
Journal:  J Thromb Haemost       Date:  2005-08       Impact factor: 5.824

Review 3.  Functional selectivity and classical concepts of quantitative pharmacology.

Authors:  Jonathan D Urban; William P Clarke; Mark von Zastrow; David E Nichols; Brian Kobilka; Harel Weinstein; Jonathan A Javitch; Bryan L Roth; Arthur Christopoulos; Patrick M Sexton; Keith J Miller; Michael Spedding; Richard B Mailman
Journal:  J Pharmacol Exp Ther       Date:  2006-06-27       Impact factor: 4.030

4.  Cryptic messages: is noncoagulant tissue factor reserved for cell signaling?

Authors:  Eric Camerer; Joann Trejo
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-19       Impact factor: 11.205

5.  PAR4, but not PAR1, signals human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation.

Authors:  Michael Holinstat; Bryan Voss; Matthew L Bilodeau; Joseph N McLaughlin; John Cleator; Heidi E Hamm
Journal:  J Biol Chem       Date:  2006-07-12       Impact factor: 5.157

6.  Disulfide isomerization switches tissue factor from coagulation to cell signaling.

Authors:  Jasimuddin Ahamed; Henri H Versteeg; Marjolein Kerver; Vivien M Chen; Barbara M Mueller; Philip J Hogg; Wolfram Ruf
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-07       Impact factor: 11.205

7.  Protective signaling by activated protein C is mechanistically linked to protein C activation on endothelial cells.

Authors:  Clemens Feistritzer; Reto A Schuepbach; Laurent O Mosnier; Leslie A Bush; Enrico Di Cera; John H Griffin; Matthias Riewald
Journal:  J Biol Chem       Date:  2006-05-18       Impact factor: 5.157

8.  The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells.

Authors:  Jong-Sup Bae; Likui Yang; Chandrashekhara Manithody; Alireza R Rezaie
Journal:  Blood       Date:  2007-09-06       Impact factor: 22.113

Review 9.  Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer.

Authors:  Puneeta Arora; Tiffany K Ricks; JoAnn Trejo
Journal:  J Cell Sci       Date:  2007-03-15       Impact factor: 5.285

10.  Receptor palmitoylation and ubiquitination regulate anthrax toxin endocytosis.

Authors:  Laurence Abrami; Stephen H Leppla; F Gisou van der Goot
Journal:  J Cell Biol       Date:  2006-01-09       Impact factor: 10.539

View more
  38 in total

Review 1.  Signal transduction by protease-activated receptors.

Authors:  Unice J K Soh; Michael R Dores; Buxin Chen; JoAnn Trejo
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

2.  Featured Article: Differential regulation of endothelial nitric oxide synthase phosphorylation by protease-activated receptors in adult human endothelial cells.

Authors:  Lakeisha C Tillery; Tenille A Epperson; Satoru Eguchi; Evangeline D Motley
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-04

3.  Cell painting with an engineered EPCR to augment the protein C system.

Authors:  Eveline A M Bouwens; Fabian Stavenuiter; Laurent O Mosnier
Journal:  Thromb Haemost       Date:  2015-08-13       Impact factor: 5.249

Review 4.  In search of analgesia: emerging roles of GPCRs in pain.

Authors:  Laura S Stone; Derek C Molliver
Journal:  Mol Interv       Date:  2009-10

5.  Functionally biased modulation of A(3) adenosine receptor agonist efficacy and potency by imidazoquinolinamine allosteric enhancers.

Authors:  Zhan-Guo Gao; Dennis Verzijl; Annelien Zweemer; Kai Ye; Anikó Göblyös; Adriaan P Ijzerman; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2011-06-21       Impact factor: 5.858

6.  Lanthanide labeling of a potent protease activated receptor-2 agonist for time-resolved fluorescence analysis.

Authors:  Justin Hoffman; Andrea N Flynn; Dipti V Tillu; Zhenyu Zhang; Renata Patek; Theodore J Price; Josef Vagner; Scott Boitano
Journal:  Bioconjug Chem       Date:  2012-10-08       Impact factor: 4.774

Review 7.  Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway.

Authors:  E A M Bouwens; F Stavenuiter; L O Mosnier
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

Review 8.  Protein C anticoagulant and cytoprotective pathways.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Int J Hematol       Date:  2012-04-05       Impact factor: 2.490

9.  Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells.

Authors:  Valérie Gratio; Nathalie Beaufort; Lina Seiz; Josefine Maier; G Duke Virca; Mekdes Debela; Nicolai Grebenchtchikov; Viktor Magdolen; Dalila Darmoul
Journal:  Am J Pathol       Date:  2010-01-07       Impact factor: 4.307

10.  Biased agonism.

Authors:  Terry Kenakin
Journal:  F1000 Biol Rep       Date:  2009-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.